McComb, S., Arbabi-Ghahroudi, M., Hay, K. A., Keller, B. A., Faulkes, S., Rutherford, M., . . . Weeratna, R. D. Discovery and preclinical development of a therapeutically active nanobody-based chimeric antigen receptor targeting human CD22. Elsevier.
Chicago Style (17th ed.) CitationMcComb, Scott, et al. Discovery and Preclinical Development of a Therapeutically Active Nanobody-based Chimeric Antigen Receptor Targeting Human CD22. Elsevier.
MLA (9th ed.) CitationMcComb, Scott, et al. Discovery and Preclinical Development of a Therapeutically Active Nanobody-based Chimeric Antigen Receptor Targeting Human CD22. Elsevier.
Warning: These citations may not always be 100% accurate.